{
    "symbol": "KBAL",
    "quarter": 1,
    "year": 2023,
    "date": "2022-11-05 15:01:04",
    "content": " First quarter sales to our core workplace and health end markets increased 20%, driven by our focus on ancillary products and secondary markets. Taking a closer look at our key end markets, workplace sales increased 22% in the first quarter, with a double-digit growth achieved across most verticals, led by commercial and education. Net sales increased 14% to $177.8 million, led by our Workplace and Health end markets. Excluding the gain as well as the acquisition-related amortization and restructuring expense, adjusted net income was $4.8 million or $0.13 per diluted share, up from an adjusted net income of $1.9 million or $0.05 per diluted share in the first quarter of fiscal 2022. Now looking at our 2023 outlook, we reaffirm our 2023 revenue guidance of $750 million to $780 million, representing approximately 15% growth at the midpoint and our adjusted EBITDA guidance of $48 million to $52 million, representing approximately 47% year-over-year growth at the midpoint."
}